International Patent: GLYCOSYLATED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND USE THEREOF

GENEVA, July 2 -- CHIMIGEN BIOMEDICAL (CHENGDU) CO., LTD. filed a patent application (CN2025/117662) for “GLYCOSYLATED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND USE THEREOF”. With publication no. WO/2026/129723, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 19/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....